ANTIHYPERTENSIVE EFFECT OF β‐1‐RECEPTOR BLOCKADE AND β‐2‐RECEPTOR STIMULATION IN ESSENTIAL HYPERTENSION
- 12 January 1975
- journal article
- clinical trial
- Published by Wiley in Acta Medica Scandinavica
- Vol. 197 (1-6), 495-496
- https://doi.org/10.1111/j.0954-6820.1975.tb04958.x
Abstract
The antihypertensive effect of practolol, a beta-1-blocker, alone and in combination with a beta-2-stimulating drug, salbutamol, has been studied in a double-blind cross-over trial on 19 patients. Practolol treatment induced a significant BP reduction, while the addition of salbutamol failed to give any further decrease.Keywords
This publication has 6 references indexed in Scilit:
- PRACTOLOL‐PROPRANOLOLActa Medica Scandinavica, 1974
- A clinical trial of long-term oral salbutamol in reversible diffuse airway obstruction.Published by Elsevier ,1973
- Prevalence and management of hypertension in a general population sample of Swedish menPreventive Medicine, 1973
- Practolol in the treatment of tachyarrhythmias in patients with bronchial asthmaAmerican Heart Journal, 1972
- Salbutamol: a new, selective β‐adrenoceptive receptor stimulantBritish Journal of Pharmacology, 1969
- Differentiation of Receptor Systems activated by Sympathomimetic AminesNature, 1967